Short-chain Fatty Acids: A Link Between Prebiotics And Microbiota In Chronic Kidney Disease

References

• NKF-KDIGO . KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.Kidney Int.3, 5 – 6 (2013).
   Web of Science ®Google Scholar
• Barros AF , BorgesNA, FerreiraDCet al. Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients? Future Microbiol. 10 (4), 517 – 526 (2015).
   PubMed Web of Science ®Google Scholar
• Mafra D , LoboJC, BarrosAF, KoppeL, VaziriND, FouqueD. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.Future Microbiol.9 (3), 399 – 410 (2014).
   PubMed Web of Science ®Google Scholar
• Vaziri ND . CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity.Curr. Opin. Nephrol. Hypertens.21 (6), 587 – 592 (2012).
   PubMed Web of Science ®Google Scholar
• Schippa S , ConteMP. Dysbiotic events in gut microbiota: impact on human health.Nutrients6 (12), 5786 – 5805 (2014).
   PubMed Web of Science ®Google Scholar
• Esgalhado M , BorgesNA, MafraD. Could physical exercise help modulate the gut microbiota in chronic kidney disease?Future Microbiol.11, 699 – 707 (2016).
   PubMed Web of Science ®Google Scholar
• Thaiss CA , ZmoraN, LevyM, ElinavE. The microbiome and innate immunity.Nature535 (7610), 65 – 74 (2016).
   PubMed Web of Science ®Google Scholar
• Prakash S , RodesL, Coussa-CharleyM, Tomaro-DuchesneauC. Gut microbiota: next frontier in understanding human health and development of biotherapeutics.Biologics5, 71 – 86 (2011).
   PubMedGoogle Scholar
• Edwards JK . Altered gut microbiota in CKD.Nat. Rev. Nephrol.12 (3), 126 (2016).
   PubMedGoogle Scholar
• Vaziri ND , WongJ, PahlMet al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 83 (2), 308 – 315 (2013).
   PubMed Web of Science ®Google Scholar
• Simenhoff ML , SaukkonenJJ, BurkeJF, WessonLG, SchaedlerRW, GordonSJ. Bacterial populations of the small intestine in uremia.Nephron22 (1–3), 63 – 68 (1978).
   PubMed Web of Science ®Google Scholar
• Carney EF . Chronic kidney disease: microbiota trigger inflammation.Nat. Rev. Nephrol.12 (7), 376 (2016).
   PubMedGoogle Scholar
• Lau WL , Kalantar-ZadehK, VaziriND. The gut as a source of inflammation in chronic kidney disease.Nephron130 (2), 92 – 98 (2015).
   PubMed Web of Science ®Google Scholar
• Mafra D , BarrosAF, FouqueD. Dietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients.Future Microbiol.8 (10), 1317 – 1323 (2013).
   PubMed Web of Science ®Google Scholar
• Hauser AB , StinghenAEM, GonçalvesSM, BucharlesS, Pecoits-filhoRA. Gut feeling on endotoxemia: causes and consequences in chronic kidney disease.Nephron Clin. Pract.118 (2), c165 – c172 (2011).
   PubMedGoogle Scholar
• National Kidney Foundation . K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Part 7. Stratification of risk for progression of kidney disease and development of cardiovascular disease, guideline 15. Association of chronic kidney disease with cardiovascular disease.Am. J. Kidney. Dis.39 (Suppl. 1), S238 – S250 (2002).
   Google Scholar
• Ramezani A , RajDS. The gut microbiome, kidney disease and targeted interventions.J. Am. Soc. Nephrol.25 (4), 657 – 670 (2014).
   PubMed Web of Science ®Google Scholar
• Kieffer DA , PiccoloBD, VaziriNDet al. Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats. Am. J. Physiol. Renal Physiol. 310 (9), F857 – F871 (2016).
   PubMed Web of Science ®Google Scholar
• Rossi M , JohnsonDW, MorrisonMet al. Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial. Clin. J. Am. Soc. Nephrol. 11 (2), 223 – 231 (2016).
   PubMed Web of Science ®Google Scholar
• Pavan M . Influence of prebiotic and probiotic supplementation on the progression of chronic kidney disease.Minerva Urol. Nefrol.68 (2), 222 – 226 (2016).
   PubMed Web of Science ®Google Scholar
• Salmean YA , SegalMS, PaliiSP, DahlWJ. Fiber supplementation lowers plasma p-cresol in chronic kidney disease patients.J. Ren. Nutr.25 (3), 316 – 320 (2015).
   PubMed Web of Science ®Google Scholar
• Vaziri ND , LiuSM, LauWLet al. High amylose resistant starch diet ameliorates oxidative stress, inflammation and progression of chronic kidney disease. PLoS ONE 9 (12), e114881 (2014).
   PubMed Web of Science ®Google Scholar
• Sirich TL , PlummerNS, GardnerCD, HostetterTH, MeyerTW. Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients.Clin. J. Am. Soc. Nephrol.9 (9), 1603 – 1610 (2014).
   PubMed Web of Science ®Google Scholar
• Koppe L , PillonNJ, VellaREet al. p-cresyl sulfate promotes insulin resistance associated with CKD. J. Am. Soc. Nephrol. 24 (1), 88 – 99 (2013).
   PubMed Web of Science ®Google Scholar
• Meijers BK , De PreterV, VerbekeK, VanrenterghemY, EvenepoelP. p-cresyl sulfate serum concentrations in hemodialysis patients are reduced by the prebiotic oligofrutose-enriched inulin.Nephrol. Dial. Transplant.25 (1), 219 – 224 (2010).
   PubMed Web of Science ®Google Scholar
• Gibson GR , ScottKP, RastallRAet al. Dietary prebiotics: current status and new definition. Food Sci. Technol. Bull. Funct. Foods 7, 1 – 19 (2010).
   Google Scholar
• Salehi-Abargouei A , GhiasvandR, HaririM. Prebiotics, prosynbiotics and synbiotics: can they reduce plasma oxidative stress parameters? A systematic review.Probiotics Antimicrob. Proteins9 (1), 1 – 11 (2017).
   PubMed Web of Science ®Google Scholar
• Valcheva R , DielemanLA. Prebiotics: definition and protective mechanisms.Best Pract. Res. Clin. Gastroenterol.30 (1), 27 – 37 (2016).
   PubMed Web of Science ®Google Scholar
• Slavin J . Fiber and prebiotics: mechanisms and health benefits.Nutrients5 (4), 1417 – 1435 (2013).
   PubMed Web of Science ®Google Scholar
• Ríos-Covián D , Ruas-MadiedoP, MargollesA, GueimondeM, de Los Reyes-GavilánCG, SalazarN. Intestinal short chain fatty acids and their link with diet and human health.Front. Microbiol.7, 185 (2016).
   PubMed Web of Science ®Google Scholar
• Puddu A , SanguinetiR, MontecuccoF, VivianiGL. Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes.Mediators Inflamm.2014, 162021 (2014).
   PubMed Web of Science ®Google Scholar
• Layden BT , AngueiraAR, BrodskyM, DuraiV, LoweWLJr. Short chain fatty acids and their receptors: new metabolic targets.Transl. Res.161 (3), 131 – 140 (2013).
   PubMed Web of Science ®Google Scholar
• Mitreva M . Human microbiome project consortium. Structure, function and diversity of the healthy human microbiome.Nature486 (7402), 207 – 214 (2012).
   PubMed Web of Science ®Google Scholar
• Power SE , O'ToolePW, StantonC, RossRP, FitzgeraldGF. Intestinal microbiota, diet and health.Br. J. Nutr.111 (3), 387 – 402 (2014).
   PubMed Web of Science ®Google Scholar
• Parks BW , NamE, KostemEet al. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab. 17 (1), 141 – 152 (2013).
   PubMed Web of Science ®Google Scholar
• Icaza-Chávez ME . Gut microbiota in health and disease.Rev. Gastroenterol. Mex.78, 240 – 248 (2013).
   PubMedGoogle Scholar
• Sommer F , BäckhedF. The gut microbiota-masters of host development and physiology.Nat. Rev. Microbiol.11 (4), 227 – 238 (2013).
   PubMed Web of Science ®Google Scholar
• Marteau P . Bacterial flora in inflammatory bowel disease.Dig. Dis.27 (Suppl. 1), 99 – 103 (2009).
   PubMedGoogle Scholar
• Ley RE , TurnbaughPJ, KleinS, GordonJI. Microbial ecology: human gut microbes associated with obesity.Nature444 (7122), 1022 – 1023 (2006).
   PubMed Web of Science ®Google Scholar
• Manco M , PutignaniL, BottazzoGF. Gut microbiota, lipopolysaccharides and innate immunity in the pathogenesis of obesity and cardiovascular risk.Endocr. Rev.31 (6), 817 – 844 (2010).
   PubMed Web of Science ®Google Scholar
• Cani PD , BibiloniR, KnaufCet al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57 (6), 1470 – 1481 (2008).
   PubMed Web of Science ®Google Scholar
• Seki E , BrennerDA. Toll-like receptors and adaptor molecules in liver disease: update.Hepatology48 (1), 322 – 335 (2008).
   PubMed Web of Science ®Google Scholar
• Tawadros PS , PowersKA, AilenbergMet al. Oxidative stress increases surface toll-like receptor 4 expression in murine macrophages via ceramide generation. Shock 44 (2), 157 – 165 (2015).
   PubMed Web of Science ®Google Scholar
• Hida M , AibaY, SawamuraS, SuzukiN, SatohT, KogaY. Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis.Nephron74 (2), 349 – 355 (1996).
   PubMed Web of Science ®Google Scholar
• Wang F , JiangH, ShiK, RenY, ZhangP, ChengS. Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients.Nephrology (Carlton)17 (8), 733 – 738 (2012).
   PubMed Web of Science ®Google Scholar
• Shi K , WangF, JiangHet al. Gut bacterial translocation may aggravate microinflammation in hemodialysis patients. Dig. Dis. Sci. 59 (9), 2109 – 2117 (2014).
   PubMed Web of Science ®Google Scholar
• Lau WL , VaziriND. Urea, a true uremic toxin: the empire strikes back.Clin. Sci. (Lond).131 (1), 3 – 12 (2017).
   PubMed Web of Science ®Google Scholar
• Stockler-Pinto MB , SaldanhaJF, YiD, MafraD, FouqueD, SoulageCO. The uremic toxin indoxyl sulfate exacerbates reactive oxygen species production and inflammation in 3T3-L1 adipose cells.Free Radic. Res.50 (3), 337 – 344 (2016).
   PubMed Web of Science ®Google Scholar
• Adelibieke Y , YisireyiliM, NgHY, SaitoS, NishijimaF, NiwaT. Indoxyl sulfate induces IL-6 expression in vascular endothelial and smooth muscle cells through OAT3-mediated uptake and activation of AhR/NF-κB pathway.Nephron Exp. Nephrol.128 (1–2), 1 – 8 (2014).
   PubMedGoogle Scholar
• Gross P , MassyZA, HenautLet al. Para-cresyl sulfate acutely impairs vascular reactivity and induces vascular remodeling. J. Cell Physiol. 230 (12), 2927 – 2935 (2015).
   PubMed Web of Science ®Google Scholar
• Bolati D , ShimizuH, YisireyiliM, NishijimaF, NiwaT. Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-kappaB.BMC Nephrol.14, 56 – 45 (2013).
   PubMed Web of Science ®Google Scholar
• Borges NA , BarrosAF, NakaoLS, DolengaCJ, FouqueD, MafraD. Protein-bound uremic toxins from gut microbiota and inflammatory markers in chronic kidney disease.J. Ren. Nutr.26 (6), 396 – 400 (2016).
   PubMed Web of Science ®Google Scholar
• Fernandez-Prado R , EsterasR, Perez-GomezMVet al. Nutrients turned into toxins: microbiota of nutrient properties in chronic kidney disease. Nutrients 9 (5), pii: E489 (2017).
   PubMed Web of Science ®Google Scholar
• Watanabe I , TatebeJ, NambaS, KoizumiM, YamazakiJ, MoritaT. Activation of aryl hydrocarbon receptor mediates indoxyl sulfate-induced monocyte chemoattractant protein-1 expression in human umbilical vein endothelial cells.Circ. J.77 (1), 224 – 230 (2013).
   PubMed Web of Science ®Google Scholar
• Wu IW , HsuKH, LeeCCet al. p-cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol. Dial. Transplant. 26 (3), 938 – 947 (2011).
   PubMed Web of Science ®Google Scholar
• Rossi M , CampbellKL, JohnsonDWet al. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3–4 chronic kidney disease. Arch. Med. Res. 45 (4), 309 – 317 (2014).
   PubMed Web of Science ®Google Scholar
• Dou L , SalléeM, CeriniCet al. The cardiovascular effect of the uremic solute indole-3 acetic acid. J. Am. Soc. Nephrol. 26 (4), 876 – 887 (2014).
   PubMed Web of Science ®Google Scholar
• Gibson GR , RoberfroidMB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics.J. Nutr.125 (6), 1401 – 1412 (1995).
   PubMed Web of Science ®Google Scholar
• Gibson GR , ProbertHM, LooJV, RastallRA, RoberfroidMB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics.Nutr. Res. Rev.17 (2), 259 – 275 (2004).
   PubMed Web of Science ®Google Scholar
• Barczynska R , BandurskaK, SlizewskaKet al. Intestinal microbiota, obesity and prebiotics. Pol. J. Microbiol. 64 (2), 93 – 100 (2015).
   PubMed Web of Science ®Google Scholar
• Reid G , BruceAW, FraserN, HeinemannC, OwenJ, HenningB. Oral probiotics can resolve urogenital infections.FEMS Immunol. Med. Microbiol.30 (1), 49 – 52 (2001).
   PubMedGoogle Scholar
• Dong JY , SzetoIM, MakinenKet al. Effect of probiotic fermented milk on blood pressure: a meta-analysis of randomised controlled trials. Br. J. Nutr. 110 (7), 1188 – 1194 (2013).
   PubMed Web of Science ®Google Scholar
• Sanchez M , DarimontC, DrapeauVet al. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br. J. Nutr. 111 (8), 1507 – 1519 (2014).
   PubMed Web of Science ®Google Scholar
• McNaught AD , WilkinsonA. IUPAC: Compendium of Chemical Terminology (2nd Edition). Blackwell Scientific Publications, Oxford, UK (1997).
   Google Scholar
• Peti-Peterdi J , KishoreBK, PluznickJL. Regulation of vascular and renal function by metabolite receptors.Annu. Rev. Physiol.78, 391 – 414 (2016).
   PubMed Web of Science ®Google Scholar
• Morrison DJ , PrestonT. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism.Gut Microbes7 (3), 189 – 200 (2016).
   PubMed Web of Science ®Google Scholar
• Kim CH , ParkJ, KimM. Gut microbiota-derived short-chain fatty acids, T cells and inflammation.Immune Netw.14 (6), 277 – 288 (2014).
   PubMedGoogle Scholar
• den Besten G , van EunenK, GroenAK, VenemaK, ReijngoudDJ, BakkerBM. The role of short-chain fatty acids in the interplay between diet, gut microbiota and host energy metabolism.J. Lipid Res.54 (9), 2325 – 2340 (2013).
   PubMed Web of Science ®Google Scholar
• Canfora EE , JockenJW, BlaakEE. Short-chain fatty acids in control of body weight and insulin sensitivity.Nat. Rev. Endocrinol.11 (10), 577 – 591 (2015).
   PubMed Web of Science ®Google Scholar
• Liu B , QianJ, WangQ, WangF, MaZ, QiaoY. Butyrate protects rat liver against total hepatic ischemia reperfusion injury with bowel congestion.PLoS ONE9 (8), e106184 (2014).
   PubMed Web of Science ®Google Scholar
• Chambers ES , ViardotA, PsichasAet al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64 (11), 1744 – 1754 (2015).
   PubMed Web of Science ®Google Scholar
• Ge H , LiX, WeiszmannJet al. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinol. 149 (9), 4519 – 4526 (2008).
   PubMed Web of Science ®Google Scholar
• de Vadder F , Kovatcheva-DatcharyP, GoncalvesDet al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156 (1–2), 84 – 96 (2014).
   PubMed Web of Science ®Google Scholar
• Cani PD , NeyrinckAM, MatonN, DelzenneNM. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like peptide-1.Obesity Res.13 (6), 1000 – 1007 (2005).
   PubMedGoogle Scholar
• Zhou J , MartinRJ, TulleyRTet al. Dietary resistant starch upregulates total GLP1 and PYY in a sustained day-long manner through fermentation in rodents. Am. J. Physiol. Endocrinol. Metab. 295 (5), E1160 – E1166 (2008).
   PubMed Web of Science ®Google Scholar
• Maslowski KM , VieiraAT, NgAet al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461 (7268), 1282 – 1286 (2009).
   PubMed Web of Science ®Google Scholar
• Bjursell M , AdmyreT, GoranssonMet al. Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. Am. J. Physiol. 300 (1), E211 – E220 (2010).
   Google Scholar
• Tolhurst G , HeffronH, LamYSet al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61 (2), 364 – 371 (2012).
   PubMed Web of Science ®Google Scholar
• Kimura I , OzawaK, InoueDet al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 4, 1829 (2013).
   PubMed Web of Science ®Google Scholar
• Arpaia N , CampbellC, FanXYet al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504 (7480), 451 – 455 (2013).
   PubMed Web of Science ®Google Scholar
• Mattace Raso G , SimeoliR, RussoRet al. Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet. PLoS ONE 8 (7), e68626 (2013).
   PubMed Web of Science ®Google Scholar
• Frost G , SleethML, Sahuri-ArisoyluMet al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat. Commun. 5, 3611 (2014).
   PubMed Web of Science ®Google Scholar
• Liu J , KandasamyS, ZhangJet al. Prebiotic effects of diet supplemented with the cultivated red seaweed Chondrus crispus or with fructo-oligosaccharide on host immunity, colonic microbiota and gut microbial metabolites. BMC Complement Altern. Med. 15, 279 (2015).
   PubMed Web of Science ®Google Scholar
• Qiao YL , QianJM, WangFR, MaZY, WangQW. Butyrate protects liver against ischemia reperfusion injury by inhibiting nuclear factor kappa B activation in Kupffer cells.J. Surg. Res.187 (2), 653 – 659 (2014).
   PubMed Web of Science ®Google Scholar
• Psichas A , SleethML, MurphyKGet al. The short chain fatty acid propionate stimulates GLP1 and PYY secretion via free fatty acid receptor 2 in rodents. Int. J. Obes. (Lond). 39 (3), 424 – 429 (2014).
   PubMed Web of Science ®Google Scholar
• Segain JP , Raingeard de la BlétièreD, BourreilleAet al. Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease. Gut 47 (3), 397 – 403 (2000).
   PubMed Web of Science ®Google Scholar
• Lührs H , GerkeT, MüllerJGet al. Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand. J. Gastroenterol. 37 (4), 458 – 466 (2002).
   PubMed Web of Science ®Google Scholar
• Cani PD , LecourtE, DewulfEMet al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am. J. Clin. Nutr. 90 (5), 1236 – 1243 (2009).
   PubMed Web of Science ®Google Scholar
• Freeland KR , WoleverTM. Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha.Br. J. Nutr.103 (3), 460 – 466 (2010).
   PubMed Web of Science ®Google Scholar
• Fernandes J , VogtJ, WoleverTM. Intravenous acetate elicits a greater free fatty acid rebound in normal than hyperinsulinaemic humans.Eur. J. Clin. Nutr.66 (9), 1029 – 1034 (2012).
   PubMed Web of Science ®Google Scholar
• Chen C , YuX, LuH, XiaoD, MaoW, LiL. Antioxidant protective effects of lactitol against endotoxemia in patients with chronic viral hepatitis.Mol. Med. Rep.7 (2), 401 – 405 (2013).
   PubMed Web of Science ®Google Scholar
• Pourghassem Gargari B , DehghanP, AliasgharzadehA, Asghari Jafar-AbadiM. Effects of high performance inulin supplementation on glycemic control and antioxidant status in women with Type 2 diabetes.Diabetes Metab. J.37 (2), 140 – 148 (2013).
   PubMedGoogle Scholar
• Cosola C , De AngelisM, RocchettiMTet al. Beta-glucans supplementation associates with reduction in P-cresyl sulfate levels and improved endothelial vascular reactivity in healthy individuals. PLoS ONE 12 (1), e0169635 (2017).
   PubMed Web of Science ®Google Scholar
• Tedelind S , WestbergF, KjerrulfM, VidalA. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease.World J. Gastroenterol.13 (20), 2826 – 2832 (2007).
   PubMed Web of Science ®Google Scholar
• Nastasi C , CandelaM, BonefeldCMet al. The effect of short-chain fatty acids on human monocyte-derived dendritic cells. Sci. Rep. 5, 16148 (2015).
   PubMed Web of Science ®Google Scholar
• Chen H , ChenL, LiuDet al. A combined clinical phenotype and lipidomic analysis reveals the impact of chronic kidney disease on lipid metabolism. J. Proteome Res. doi:10.1021/acs.jproteome.6b00956 (2017 ) ( Epub ahead of print).
   Web of Science ®Google Scholar
• Koppe L , PelletierCC, AlixPMet al. Insulin resistant in chronic kidney disease: new lessons from experimental models. Nephrol. Dial. Transplant. 29 (9), 1666 – 1674 (2014).
   PubMed Web of Science ®Google Scholar
• Hill NR , FatobaST, OkeJLet al. Global prevalence of chronic kidney disease – a systematic review and meta-analysis. PLoS ONE 11 (7), e0158765 (2016).
   PubMed Web of Science ®Google Scholar
• Machowska A , CarreroJJ, LindholmB, StenvinkelP. Therapeutics targeting persistent inflammation in chronic kidney disease.Transl. Res.167 (1), 204 – 213 (2016).
   PubMed Web of Science ®Google Scholar
• Modaresi A , NafarM, SahraeiZ. Oxidative stress in chronic kidney disease.Iran J. Kidney Dis.9 (3), 165 – 179 (2015).
   PubMed Web of Science ®Google Scholar
• Pashkow FJ . Oxidative stress and inflammation in heart disease: do antioxidants have a role in treatment and/or prevention?Int. J. Inflam.2011, 514623 (2011).
   PubMedGoogle Scholar
• Kobayashi M , MikamiD, KimuraHet al. Short-chain fatty acids, GPR41 and GPR43, ligands, inhibit TNF-α-induced MCP 1 expression by modulating p38 and JNK signaling pathways in human renal cortical epithelial cells. Biochem. Biophys. Res. Commun. 486 (2), 499 – 505 (2017).
   PubMed Web of Science ®Google Scholar
• Andrade-Oliveira V , AmanoMT, Correa-CostaMet al. Gut bacteria products prevent AKI induced by ischemia-reperfusion. J. Am. Soc. Nephrol. 26 (8), 1877 – 1888 (2015).
   PubMed Web of Science ®Google Scholar